Liquidia Corp
NASDAQ:LQDA

Watchlist Manager
Liquidia Corp Logo
Liquidia Corp
NASDAQ:LQDA
Watchlist
Price: 11.44 USD 3.06% Market Closed
Market Cap: 968.3m USD
Have any thoughts about
Liquidia Corp?
Write Note

Wall Street
Price Targets

LQDA Price Targets Summary
Liquidia Corp

Wall Street analysts forecast LQDA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LQDA is 25.81 USD with a low forecast of 17.17 USD and a high forecast of 32.55 USD.

Lowest
Price Target
17.17 USD
50% Upside
Average
Price Target
25.81 USD
126% Upside
Highest
Price Target
32.55 USD
185% Upside

LQDA Last Price Targets
Liquidia Corp

The latest public price target was made on Aug 20, 2024 by Jason Gerberry from Bank of America Securities , who expects LQDA stock to rise by 101% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Jason Gerberry
Bank of America Securities
23 USD
Upside 101%
4 months ago
Aug 20, 2024
Liquidia price target lowered to $23 from $24 at BofA
TheFly
Strong Buy
Raymond James
27 USD
Upside 136%
4 months ago
Aug 19, 2024
Liquidia upgraded to Strong Buy from Outperform at Raymond James
TheFly
Kambiz Yazdi
Jefferies
17 USD
Upside 49%
4 months ago
Aug 19, 2024
Liquidia price target lowered to $17 from $22 at Jefferies
TheFly
Kambiz Yazdi
Jefferies
23 USD
Upside 101%
7 months ago
May 14, 2024
Liquidia Technologies (LQDA) PT Lowered to $23 at Jefferies
StreetInsider
Jason Gerberry
Bank of America Securities
Price Target 23 USD
Upside/Downside 101%
View Source
Strong Buy
Raymond James
Price Target 27 USD
Upside/Downside 136%
View Source
Kambiz Yazdi
Jefferies
Price Target 17 USD
Upside/Downside 49%
View Source
Kambiz Yazdi
Jefferies
Price Target 23 USD
Upside/Downside 101%
View Source
Liquidia Corp Competitors:
Price Targets
AMLX
Amylyx Pharmaceuticals Inc
100% Upside
4886
ASKA Pharmaceutical Holdings Co Ltd
21% Upside
000513
Livzon Pharmaceutical Group Inc
8% Upside
ORNBV
Orion Oyj
20% Upside
1795
Lotus Pharmaceutical Co Ltd
68% Upside
ROVI
Laboratorios Farmaceuticos ROVI SA
51% Upside
002332
Zhejiang Xianju Pharmaceutical Co Ltd
61% Upside

Revenue
Forecast

Revenue Estimate
Liquidia Corp

For the last 6 years the compound annual growth rate for Liquidia Corp's revenue is 16%. The projected CAGR for the next 4 years is 101%.

16%
Past Growth
101%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Liquidia Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Liquidia Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-48%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LQDA's stock price target?
Price Target
25.81 USD

According to Wall Street analysts, the average 1-year price target for LQDA is 25.81 USD with a low forecast of 17.17 USD and a high forecast of 32.55 USD.

What is Liquidia Corp's Revenue forecast?
Projected CAGR
101%

For the last 6 years the compound annual growth rate for Liquidia Corp's revenue is 16%. The projected CAGR for the next 4 years is 101%.

Back to Top